THE USE OF CANNABIS FOR HEADACHE DISORDER: A REVIEW
BRYSON C. LOCHTE, ALEXANDER BELETSKY, NEBIYOU K. SAMUEL, AND IGOR GRANT, CANNABIS AND CANNABINOID RESEARCH VOLUME 2.1, 2017, DOI: 10.1089/can.2016.0033
The review compiles various preclinical studies into a prospective integrated model outlining the role of cannabinoids in the modulation of headache pathogenesis. The review found that it is likely that cannabis will emerge as a potential treatment for some headache sufferers but highlighted the need for placebo controlled clinical trials to appropriately determine efficacy.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.